97 related articles for article (PubMed ID: 34341522)
1. Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.
Yanes T; Meiser B; Kaur R; Young MA; Mitchell PB; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Betz-Stablein B; James PA
Genet Med; 2021 Dec; 23(12):2316-2323. PubMed ID: 34341522
[TBL] [Abstract][Full Text] [Related]
2. Women's responses and understanding of polygenic breast cancer risk information.
Yanes T; Kaur R; Meiser B; Scheepers-Joynt M; McInerny S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; James PA; Young MA
Fam Cancer; 2020 Oct; 19(4):297-306. PubMed ID: 32430685
[TBL] [Abstract][Full Text] [Related]
3. Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: 'Another piece of the pie'.
Willis AM; Smith SK; Meiser B; James PA; Ballinger ML; Thomas DM; Yanes T; Young MA
J Genet Couns; 2021 Jun; 30(3):849-860. PubMed ID: 33470033
[TBL] [Abstract][Full Text] [Related]
4. Uptake of polygenic risk information among women at increased risk of breast cancer.
Yanes T; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Young MA; James PA
Clin Genet; 2020 Mar; 97(3):492-501. PubMed ID: 31833054
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.
Yanes T; Meiser B; Young MA; Kaur R; Mitchell G; Barlow-Stewart K; Roscioli T; Halliday J; James P
BMC Cancer; 2017 Jul; 17(1):491. PubMed ID: 28720130
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer polygenic risk scores in the clinical cancer genetic counseling setting: Current practices and impact on patient management.
McGuinness M; Fassi E; Wang C; Hacking C; Ellis V
J Genet Couns; 2021 Apr; 30(2):588-597. PubMed ID: 33124135
[TBL] [Abstract][Full Text] [Related]
7. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up.
Stan DL; Kim JO; Schaid DJ; Carlson EE; Kim CA; Sinnwell JP; Couch FJ; Vachon CM; Cooke AL; Goldenberg BA; Pruthi S
Cancer Prev Res (Phila); 2024 Feb; 17(2):77-84. PubMed ID: 38154464
[TBL] [Abstract][Full Text] [Related]
9. Communicating polygenic risk scores in the familial breast cancer clinic.
Das Gupta K; Gregory G; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; McInerney-Leo A; Young MA; James PA; Yanes T
Patient Educ Couns; 2021 Oct; 104(10):2512-2521. PubMed ID: 33706980
[TBL] [Abstract][Full Text] [Related]
10. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
11. Exploration of experiences with and understanding of polygenic risk scores for bipolar disorder.
Putt S; Yanes T; Meiser B; Kaur R; Fullerton JM; Barlow-Stewart K; Schofield PR; Toma C; Peay H; Mitchell PB
J Affect Disord; 2020 Mar; 265():342-350. PubMed ID: 32090758
[TBL] [Abstract][Full Text] [Related]
12. Predictors of breast cancer screening behavior in women with a strong family history of the disease.
Price MA; Butow PN; Charles M; Bullen T; Meiser B; McKinley JM; McLachlan SA; Phillips KA; ;
Breast Cancer Res Treat; 2010 Nov; 124(2):509-19. PubMed ID: 20364401
[TBL] [Abstract][Full Text] [Related]
13. Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk.
Kaur R; Meiser B; Yanes T; Young MA; Barlow-Stewart K; Roscioli T; Smith S; James PA
Fam Cancer; 2019 Apr; 18(2):147-152. PubMed ID: 30251170
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
15. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review.
Meiser B; Halliday JL
Soc Sci Med; 2002 May; 54(10):1463-70. PubMed ID: 12061481
[TBL] [Abstract][Full Text] [Related]
16. The role of polygenic risk and susceptibility genes in breast cancer over the course of life.
Mars N; Widén E; Kerminen S; Meretoja T; Pirinen M; Della Briotta Parolo P; Palta P; ; Palotie A; Kaprio J; Joensuu H; Daly M; Ripatti S
Nat Commun; 2020 Dec; 11(1):6383. PubMed ID: 33318493
[TBL] [Abstract][Full Text] [Related]
17. A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.
Vachon CM; Schaid DJ; Ingle JN; Wickerham DL; Kubo M; Mushiroda T; Goetz MP; Carlson EE; Paik S; Wolmark N; Nakamura Y; Wang L; Weinshilboum R; Couch FJ
Breast Cancer Res Treat; 2015 Jan; 149(2):517-23. PubMed ID: 25575444
[TBL] [Abstract][Full Text] [Related]
18. A role for common genomic variants in the assessment of familial breast cancer.
Sawyer S; Mitchell G; McKinley J; Chenevix-Trench G; Beesley J; Chen XQ; Bowtell D; Trainer AH; Harris M; Lindeman GJ; James PA
J Clin Oncol; 2012 Dec; 30(35):4330-6. PubMed ID: 23109704
[TBL] [Abstract][Full Text] [Related]
19. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-
Lakeman IMM; Hilbers FS; Rodríguez-Girondo M; Lee A; Vreeswijk MPG; Hollestelle A; Seynaeve C; Meijers-Heijboer H; Oosterwijk JC; Hoogerbrugge N; Olah E; Vasen HFA; van Asperen CJ; Devilee P
J Med Genet; 2019 Sep; 56(9):581-589. PubMed ID: 31186341
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
